Rubino DM, Pedersen SD, Connery L, Cao D, et al. Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials. Diabetes Obes Metab 2025 Jan 9. doi: 10.1111/dom.16176.
PMID: 39789843